Cervical Selective Nerve Root Injection Protocol
For cervical selective nerve root injections, use fluoroscopy-guided technique with an anterolateral oblique approach, inject 3-4 mL total volume containing local anesthetic (1% lidocaine 1 mL) plus steroid (betamethasone 4 mg or dexamethasone 4 mg), and confirm needle position with contrast before therapeutic injection. 1, 2, 3
Technical Approach
Imaging Guidance
- Fluoroscopy remains the gold standard for cervical selective nerve root blocks, with extensive safety data from over 4,600 procedures showing no serious neurologic complications when performed by experienced operators 3
- Ultrasound-guided technique is emerging as an alternative with comparable effectiveness and no radiation exposure, though requires specific expertise 4, 5
- Mandatory contrast injection (minimum 2 projection views) before therapeutic substances to confirm extraforaminal needle placement and rule out vascular uptake 2, 3
Needle Positioning
- Use anterolateral oblique approach targeting the extraforaminal space
- Position needle tip at the posterior aspect of the neural foramen, avoiding intravascular or intrathecal placement
- If venous opacification persists despite repositioning, abort the procedure 2
Injectate Composition
Steroid Selection
Use betamethasone 4 mg (1 mL) as first choice based on the most recent 2026 comparative data showing superior pain reduction at day 14 (between-group difference -1.55 points, p=0.0077) 1. This represents the highest quality recent evidence directly comparing steroid versus no-steroid protocols.
Alternative: Dexamethasone 4 mg is acceptable as a non-particulate steroid, though 2009 data suggested slightly lower effectiveness (69.4% vs 80.4% for triamcinolone, not statistically significant) 6. The non-particulate property theoretically reduces embolic risk, though no embolic events occurred in large safety series with either agent.
Volume and Mixture
- Total volume: 3-4 mL
- 1% lidocaine: 1 mL
- Normal saline: 2-3 mL
- Steroid: 1 mL (betamethasone 4 mg or dexamethasone 4 mg)
- This protocol from the 2026 study 1 showed no procedure-related complications in 70 patients
Safety Considerations
Critical Pitfalls to Avoid
- Never inject without contrast confirmation - this is the single most important safety measure 2, 3
- Abort if persistent venous opacification occurs despite needle repositioning 2
- Avoid particulate steroids in transforaminal approach if concerned about embolic risk, though large series show safety with proper technique 6, 3
Expected Complications
Minor complications occur in ~4% of cases (33/799 procedures), most commonly vasovagal symptoms 2. No serious neurologic complications (stroke, spinal cord injury, permanent nerve deficit) occurred in the largest safety series of 4,612 procedures 3.
Post-Procedure Monitoring
- Assess immediately and at 30 minutes post-procedure 2
- For hypertensive patients: 78% experience transient blood pressure elevation requiring monitoring 7
- For diabetic patients: 92% develop transient hyperglycemia requiring glucose monitoring 7
Contraindications to Procedure
- Patient anxiety preventing cooperation 2
- Challenging body habitus preventing safe access 2
- Active infection
- Coagulopathy (relative contraindication)
Context from Guidelines
The 2025 BMJ guideline 8 addresses epidural injections for chronic spine pain but notes very low certainty evidence for benefit and emphasizes that patients would be disinclined to receive interventions with low certainty of benefit. However, this guideline focused on chronic axial pain rather than acute radiculopathy, which is the primary indication for selective nerve root blocks. The selective nerve root block serves both diagnostic and therapeutic purposes in radiculopathy that are distinct from the chronic pain interventions evaluated in that guideline.